Page 120 - 《中国药房》2022年14期

service for patients with psychiatric disorders[J]. Pharma- 1069-1078.
cotherapy，2014，34（12）：1336-1340. [30] RAFFERTY E，YAGHOUBI M，TAYLOR J，et al. Costs
[18] GALLAGHER J，BYRNE S，WOODS N，et al. Cost-out- and savings associated with a pharmacists prescribing for
come description of clinical pharmacist interventions in a minor ailments program in Saskatchewan[J]. Cost Eff
university teaching hospital[J]. BMC Health Serv Res， Resour Alloc，2017，15：3.
2014，14：177. [31] BAO Z W，JI C M，HU J，et al. Clinical and economic
[19] LU T H，LEE Y Y，TSAI S C，et al. The outcome of clini- impact of pharmacist interventions on sampled outpatient
cal pharmacists’interventions in a Taiwanese hospital on prescriptions in a Chinese teaching hospital[J]. BMC
pharmacoeconomics and cost saving[J]. J Exp Clin Med， Health Serv Res，2018，18（1）：519.
2014，6（4）：139-142. [32] BOSMA B E，VAN DEN BEMT P M L A，MELIEF P H
[20] NEVILLE H L，CHEVALIER B，DALEY C，et al. Clini- G J，et al. Pharmacist interventions during patient rounds
cal benefits and economic impact of post-surgical care pro- in two intensive care units：clinical and financial impact[J].
vided by pharmacists in a Canadian hospital[J]. Int J Neth J Med，2018，76（3）：115-124.
Pharm Pract，2014，22（3）：216-222. [33] BOSMA L B E，HUNFELD N G M，QUAX R A M，et al.
[21] SEBAALY J，PARSONS L B，PILCH N A，et al. Clinical The effect of a medication reconciliation program in two
and financial impact of pharmacist involvement in dis- intensive care units in the Netherlands：a prospective inter-
charge medication reconciliation at an academic medical vention study with a before and after design[J]. Ann Inten-
center：a prospective pilot study[J]. Hosp Pharm，2015，50 sive Care，2018，8（1）：19.
（6）：505-513. [34] 陈敏，张伶俐，张川，等.儿科临床药师药学服务的成本-
[22] WANG J W，DONG M H，LU Y，et al. Impact of pharma- 效益分析[J].中国药房，2018，29（4）：483-486.
cist interventions on rational prophylactic antibiotic use [35] JOURDAN J P，MUZARD A，GOYER I，et al. Impact of
and cost saving in elective cesarean section[J]. Int J Clin pharmacist interventions on clinical outcome and cost
Pharmacol Ther，2015，53（8）：605-615. avoidance in a university teaching hospital[J]. Int J Clin
[23] AH Y M，LEE J Y，MOON M R，et al. Clinical and eco- Pharm，2018，40（6）：1474-1481.
nomic evaluation of pharmacists’contribution to patient [36] ONATADE R，QUAYE S. Economic value of pharmacy-
care on a multi-disciplinary liver transplant team[J]. Int J led medicines reconciliation at admission to hospital：an
Clin Pharmacol Ther，2016，54（2）：102-109. observational，UK-based study[J]. Eur J Hosp Pharm，
[24] HAN J M，AH Y M，SUH S Y，et al. Clinical and econo- 2018，25（1）：26-31.
mic impact of pharmacists’intervention in a large volume [37] RAVICHANDRAN B R，GILLESPIE M W，SPARKES T M，
chemotherapy preparation unit[J]. Int J Clin Pharm，2016， et al. Collaborative practice agreement in solid organ
38（5）：1124-1132. transplantation[J]. Int J Clin Pharm，2018，40（2）：474-479.
[25] IBÁÑEZ-GARCIA S，RODRIGUEZ-GONZALEZ C G， [38] HAMMOND D A，FLOWERS H J C，MEENA N，et al.
MARTIN-BARBERO M L，et al. Adding value through Cost avoidance associated with clinical pharmacist pre-
pharmacy validation：a safety and cost perspective[J]. J sence in a medical intensive care unit[J]. J Am Coll Clin
Eval Clin Pract，2016，22（2）：253-260. Pharm，2019，2（6）：610-615.
[26] RYCHLÍČKOVÁ J，ŠALOUN J，GREGOROVÁ J. Eva- [39] AL-QUDAH R A，AL-BADRIYEH D，AL-ALI F M，et al.
luation of clinical pharmacists’interventions in the Czech Cost-benefit analysis of clinical pharmacist intervention in
republic[J]. Pharmacotherapy，2016，36（7）：766-773. preventing adverse drug events in the general chronic
[27] CHEN C C，HSIAO F Y，SHEN L J，et al. The cost-saving diseases outpatients[J]. J Eval Clin Pract，2020，26（1）：
effect and prevention of medication errors by clinical 115-124.
pharmacist intervention in a nephrology unit[J]. Medicine [40] CAZARIM M S，RODRIGUES J P V，CALCINI P S，et al.
（Baltimore），2017，96（34）：e7883. Cost-benefit analysis of pharmacist interventions over 36
[28] LUO H L，FAN Q Z，XIAO S L，et al. Impact of clinical months in a university hospital[J]. Rev Saude Publica，
pharmacist interventions on inappropriate prophylactic 2020，54：94.
acid suppressant use in hepatobiliary surgical patients [41] CHEN P Z，WU C C，HUANG C F. Clinical and economic
undergoing elective operations[J]. PLoS One，2017，12 impact of clinical pharmacist intervention in a hematology
（10）：e0186302. unit[J]. J Oncol Pharm Pract，2020，26（4）：866-872.
[29] MALET-LARREAA，GOYENECHEA E，GASTELURRUTIA [42] DE GRÉGORI J，PISTRE P，BOUTET M，et al. Clinical
M A，et al. Cost analysis and cost-benefit analysis of a and economic impact of pharmacist interventions in an
medication review with follow-up service in aged poly- ambulatory hematology-oncology department[J]. J Oncol
pharmacy patients[J]. Eur J Health Econ，2017，18（9）： Pharm Pract，2020，26（5）：1172-1179.

·1774 · China Pharmacy 2022 Vol. 33 No. 14 中国药房 2022年第33卷第14期